Article Information
- Received September 8, 1999
- Revision received October 19, 1999
- Accepted October 21, 1999
- First published January 15, 2000.
- Version of record published January 15, 2000.
Author Information
- Lloyd D. Fricker1,
- Audra A. McKinzie2,
- Jilin Sun2,
- Eileen Curran2,
- Yimei Qian1,
- Lin Yan1,
- Scott D. Patterson3,
- Paul L. Courchesne3,
- Bill Richards2,
- Nancy Levin2,
- Nino Mzhavia4,
- Lakshmi A. Devi4, and
- James Douglass2
- 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, Departments of
- 2Neuroendocrinology and
- 3Mammalian Genomics, Amgen, Thousand Oaks, California 91360-1789, and
- 4Department of Pharmacology, New York University School of Medicine, New York, New York 10016
Author contributions
Disclosures
- Received September 8, 1999.
- Revision received October 19, 1999.
- Accepted October 21, 1999.
This work was supported primarily by Amgen and also by National Institutes of Health Grants R01 DA-04494, K02 DA-00194 (L.D.F.), R01 NS-26880, and K04 NS-01788 (L.A.D.). Some of the mass spectrometry was performed in the Laboratory for Macromolecular Analysis of the Albert Einstein College of Medicine, which is supported in part by the Cancer Center Core grant CA13330 and by the Diabetes Research Training Center Core grant DK20541. Confocal microscopy was performed in the Analytical Imaging Facility of the Albert Einstein College of Medicine. Wei Fan is gratefully acknowledged for performing the SAAS gene-mapping studies. Iris Lindberg and Nabil Seidah generously provided PC1 expression systems and Michael McCaleb, Ruth Angeletti, Ed Nieves, and Hong Li provided helpful advice.
Correspondence should be addressed to Dr. Lloyd Fricker, Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. E-mail: fricker{at}aecom.yu.edu.
Online Impact